News
Publications
Read more about Nycomed in our
Company Brochure 2009 
Annual Report 2008
Last quaterly report
Where we work
Nycomed is present in over 50 countries.

Find your local Nycomed website and office and the way to our headquarters in Zurich, Switzerland.
Financial reports
Read our financial reports
Events
Find out what events are coming up
 Soft-Relaunch Pictures
About us
Nycomed is a privately owned global pharmaceutical company with a differentiated portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. An extensive range of OTC products completes the portfolio.

Its R&D is structured around partnerships, and in-licensing is a cornerstone of the company’s growth strategy.
The company employs 12,000 associates worldwide, and its products are available in more than 100 countries. It has strong platforms in Europe and in fast-growing markets such as Russia/CIS, and Latin America. While the US and Japan are commercialised through best-in-class partners, Nycomed plans to further strengthen its own position in key Asian markets.

Headquartered in Zurich, Switzerland, the company generated total sales of
€ 3,2 billion in 2009 and an adjusted EBITDA of € 1,1 billion.